Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy

The two main objectives of this analysis were to (i) characterize the relationship between immunoglobulin (Ig) exposure and chronic inflammatory demyelinating polyneuropathy (CIDP) disease severity using data from 171 patients with CIDP who received either subcutaneous Ig (IgPro20; Hizentra(®)) or p...

Descripción completa

Detalles Bibliográficos
Autores principales: Tortorici, Michael A., Yuraszeck, Theresa, Cornblath, David, Bril, Vera, Hartung, Hans‐Peter, Sobue, Gen, Lewis, Richard A., Merkies, Ingemar S. J., Lawo, John‐Philip, Praus, Michaela, Durn, Billie L., Mielke, Orell, Ma, Xuewen, Jauslin, Petra, Pfister, Marc, van Schaik, Ivo N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376132/
https://www.ncbi.nlm.nih.gov/pubmed/34085779
http://dx.doi.org/10.1002/psp4.12647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376132/
https://www.ncbi.nlm.nih.gov/pubmed/34085779
http://dx.doi.org/10.1002/psp4.12647

Ejemplares similares